You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Continue
Contact

Fusion

Fusion

Fusion Hybrid Vascular Grafts

Fusion

Vascular Grafts

Combining ePTFE with PET

Questions? Ask us about Fusion

Overview

The inner layer is comprised of ePTFE.[1] The outer layer is a knit polyester textile.[1] These two layers are fused together with a proprietary polycarbonate-urethane.

  • Smooth luminal surface of ePTFE[2]
  • Tissue ingrowth properties of PET[1]

Delivering benefits both during and post-procedure

  • Designed to provide minimal suture hole bleeding[1] for improved hemostasis
  • Axial compliance designed to reduce tension on the anastomosis[1]
Fusion Hybrid Vascular Grafts

Fusion-hybrid-needle-880x600.jpg

High suture retention strength[1]

Support Coil.jpg

Removable radiopaque continous support coil[1]

PERFECTION Trial Overview

The PERFECTION trial was a prospective, multi-center study designed to assess the clinical efficacy of the novel Fusion vascular graft.[3]

  • 117 patients underwent femoral-popliteal bypass with the Fusion vascular graft
  • Duplex ultrasound imaging and ankle-brachial indices were performed at 30 days, 6 months and 12 months
  • The primary efficacy end point was 12-month primary patency

Results

  • The 30-day primary graft patency was 95.3%
  • The 12-month primary rate was 85.6%, and the secondary patency rate was 93.2%
  • Ankle-brachial indices increased from a mean of 0.53 +/- 0.20 preoperatively to 0.97 +/- 0.16 at 30 days and 0.91 +/- 0.22 at 12 months

Patency rates equaled or exceed those reported with other nonbioactive vascular grafts and compare favorably with data from many studies of heparin-coated prostheses.

Conclusion
The PERFECTION trial concluded that the Fusion vascular graft is an effective alternative to ePTFE grafts and should be considered as an option in patients requiring femoral-popliteal arterial reconstruction.

Straight 

Diameter   Length Reference
5 mm 40 cm M002015010450
5 mm 80 cm M002015010850
6 mm 20 cm M002015010260
6 mm 40 cm M002015010460
6 mm 60 cm M002015010660
6 mm 80 cm M002015010860
7 mm 40 cm M002015010470
7 mm 80 cm M002015010870
8 mm 40 cm M002015010480
8 mm 60 cm M002015010680
8 mm 80 cm M002015010880
10 mm 40 cm M002015010410
10 mm 80 cm M002015010810

Helix supported 

Diameter   Length Reference
5 mm 40 cm M002015030450
5 mm 80 cm M002015030850
6 mm 40 cm M002015030460
6 mm 60 cm M002015030660
6 mm 80 cm M002015030860
7 mm 40 cm M002015030470
7 mm 80 cm M002015030870
8 mm 40 cm M002015030480
8 mm 60 cm M002015030680
8 mm 80 cm M002015030880
10 mm 40 cm M002015030410
10 mm 80 cm M002015030810

All grafts are fully supported except 3 cm on 1 end.

All references

  1. Data on file

  2. Cronwett & Johnston et al., Rutherford’s Vascular Surgery 8th ed., Vol 2, Elsevier, 2014

  3. Assadian, A. and H.H. Eckstein, Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass. J Vasc Surg, 2015. 61(3): p. 713-9.e1

Subscription